Tango Therapeutics IncNASDAQ:TNGX
- LAST PRICE7.6100
- TODAY'S CHANGE (%)0.6900 (9.9711%)
- Bid / Lots7.4000/ 1
- Ask / Lots7.9000/ 19
- Open / Previous Close7.1100 / 6.9200
- Day Range
- 52 Week Range
- Volume700,295
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TNGX |
|---|---|---|
| 09:32 ET | 5702 | 7.18 |
| 09:34 ET | 574 | 7.24 |
| 09:36 ET | 100 | 7.175 |
| 09:38 ET | 2675 | 7.12 |
| 09:39 ET | 2100 | 7.16 |
| 09:41 ET | 2225 | 7.17 |
| 09:43 ET | 200 | 7.15 |
| 09:45 ET | 200 | 7.145 |
| 09:48 ET | 400 | 7.14 |
| 09:50 ET | 2600 | 7.11 |
| 09:52 ET | 600 | 7.15 |
| 09:54 ET | 704 | 7.14 |
| 10:01 ET | 9259 | 7.28 |
| 10:03 ET | 1300 | 7.25 |
| 10:08 ET | 1828 | 7.24 |
| 10:10 ET | 1374 | 7.28 |
| 10:14 ET | 615 | 7.31 |
| 10:15 ET | 20044 | 7.305 |
| 10:19 ET | 2607 | 7.295 |
| 10:21 ET | 586 | 7.34 |
| 10:24 ET | 120 | 7.35 |
| 10:26 ET | 6036 | 7.34 |
| 10:30 ET | 200 | 7.32 |
| 10:32 ET | 925 | 7.325 |
| 10:33 ET | 1176 | 7.33 |
| 10:35 ET | 800 | 7.34 |
| 10:37 ET | 1100 | 7.305 |
| 10:39 ET | 479 | 7.31 |
| 10:42 ET | 1200 | 7.24 |
| 10:44 ET | 1400 | 7.26 |
| 10:51 ET | 500 | 7.25 |
| 10:53 ET | 1809 | 7.3 |
| 10:55 ET | 221 | 7.31 |
| 11:00 ET | 1500 | 7.29 |
| 11:02 ET | 845 | 7.28 |
| 11:06 ET | 732 | 7.3 |
| 11:08 ET | 422 | 7.31 |
| 11:09 ET | 10249 | 7.27 |
| 11:13 ET | 1324 | 7.28 |
| 11:15 ET | 171 | 7.28 |
| 11:18 ET | 650 | 7.275 |
| 11:24 ET | 13607 | 7.34 |
| 11:26 ET | 200 | 7.34 |
| 11:27 ET | 100 | 7.35 |
| 11:31 ET | 300 | 7.35 |
| 11:33 ET | 700 | 7.34 |
| 11:36 ET | 107 | 7.345 |
| 11:42 ET | 100 | 7.35 |
| 11:44 ET | 500 | 7.35 |
| 11:47 ET | 5079 | 7.4 |
| 11:51 ET | 100 | 7.39 |
| 11:56 ET | 2239 | 7.4 |
| 11:58 ET | 364 | 7.405 |
| 12:03 ET | 300 | 7.4 |
| 12:09 ET | 515 | 7.4 |
| 12:12 ET | 1952 | 7.39 |
| 12:14 ET | 673 | 7.39 |
| 12:16 ET | 3295 | 7.36 |
| 12:18 ET | 2180 | 7.37 |
| 12:21 ET | 800 | 7.37 |
| 12:23 ET | 1351 | 7.36 |
| 12:25 ET | 900 | 7.34 |
| 12:30 ET | 1548 | 7.34 |
| 12:32 ET | 4562 | 7.375 |
| 12:34 ET | 1943 | 7.355 |
| 12:36 ET | 500 | 7.37 |
| 12:38 ET | 600 | 7.39 |
| 12:39 ET | 1024 | 7.39 |
| 12:43 ET | 800 | 7.38 |
| 12:45 ET | 200 | 7.38 |
| 12:48 ET | 1203 | 7.38 |
| 12:50 ET | 3070 | 7.35 |
| 12:56 ET | 3024 | 7.37 |
| 12:57 ET | 500 | 7.36 |
| 12:59 ET | 300 | 7.35 |
| 01:01 ET | 1350 | 7.37 |
| 01:03 ET | 900 | 7.3725 |
| 01:10 ET | 300 | 7.37 |
| 01:14 ET | 795 | 7.39 |
| 01:15 ET | 4755 | 7.39 |
| 01:17 ET | 1553 | 7.395 |
| 01:19 ET | 3294 | 7.41 |
| 01:24 ET | 1900 | 7.4 |
| 01:26 ET | 400 | 7.395 |
| 01:28 ET | 900 | 7.395 |
| 01:30 ET | 600 | 7.395 |
| 01:32 ET | 750 | 7.395 |
| 01:33 ET | 850 | 7.385 |
| 01:35 ET | 600 | 7.4 |
| 01:37 ET | 300 | 7.4 |
| 01:39 ET | 200 | 7.4 |
| 01:42 ET | 407 | 7.41 |
| 01:44 ET | 100 | 7.4 |
| 01:48 ET | 1459 | 7.4 |
| 01:50 ET | 200 | 7.41 |
| 01:51 ET | 10719 | 7.46 |
| 01:53 ET | 2600 | 7.48 |
| 01:55 ET | 4544 | 7.48 |
| 01:57 ET | 5650 | 7.5 |
| 02:00 ET | 900 | 7.49 |
| 02:02 ET | 4000 | 7.44 |
| 02:04 ET | 1000 | 7.455 |
| 02:06 ET | 500 | 7.48 |
| 02:08 ET | 1664 | 7.5 |
| 02:09 ET | 969 | 7.5 |
| 02:11 ET | 400 | 7.495 |
| 02:13 ET | 781 | 7.48 |
| 02:15 ET | 786 | 7.4622 |
| 02:18 ET | 1449 | 7.5 |
| 02:20 ET | 1906 | 7.49 |
| 02:22 ET | 1294 | 7.49 |
| 02:24 ET | 400 | 7.49 |
| 02:26 ET | 915 | 7.49 |
| 02:27 ET | 155 | 7.49 |
| 02:29 ET | 1117 | 7.5 |
| 02:31 ET | 2637 | 7.5 |
| 02:33 ET | 8539 | 7.5 |
| 02:36 ET | 2590 | 7.55 |
| 02:38 ET | 1461 | 7.565 |
| 02:40 ET | 500 | 7.56 |
| 02:42 ET | 609 | 7.56 |
| 02:44 ET | 1685 | 7.55 |
| 02:45 ET | 1870 | 7.55 |
| 02:47 ET | 1535 | 7.55 |
| 02:49 ET | 10057 | 7.55 |
| 02:51 ET | 1291 | 7.56 |
| 02:54 ET | 1032 | 7.55 |
| 02:56 ET | 206 | 7.55 |
| 02:58 ET | 2850 | 7.57 |
| 03:00 ET | 876 | 7.56 |
| 03:02 ET | 2847 | 7.58 |
| 03:03 ET | 930 | 7.6 |
| 03:05 ET | 1100 | 7.6 |
| 03:07 ET | 1686 | 7.58 |
| 03:12 ET | 5325 | 7.625 |
| 03:14 ET | 5854 | 7.64 |
| 03:16 ET | 2700 | 7.64 |
| 03:18 ET | 1600 | 7.65 |
| 03:20 ET | 8400 | 7.625 |
| 03:21 ET | 200 | 7.61 |
| 03:23 ET | 1047 | 7.58 |
| 03:25 ET | 847 | 7.59 |
| 03:27 ET | 1258 | 7.5 |
| 03:30 ET | 2653 | 7.49 |
| 03:32 ET | 1953 | 7.46 |
| 03:34 ET | 650 | 7.47 |
| 03:36 ET | 1062 | 7.47 |
| 03:38 ET | 2531 | 7.505 |
| 03:39 ET | 10146 | 7.565 |
| 03:41 ET | 2772 | 7.56 |
| 03:43 ET | 5324 | 7.57 |
| 03:45 ET | 2214 | 7.59 |
| 03:48 ET | 8433 | 7.64 |
| 03:50 ET | 5076 | 7.64 |
| 03:52 ET | 9947 | 7.7 |
| 03:54 ET | 12155 | 7.7 |
| 03:56 ET | 15027 | 7.67 |
| 03:57 ET | 12436 | 7.66 |
| 03:59 ET | 199930 | 7.61 |
Jun 5, 2024
Tango Therapeutics to Present at the Goldman Sachs 45(th) Annual Global Healthcare Conference, from 7:00AM ET on Wednesday Jun 05, 2024 by Dow Jones
7:00AM ET on Wednesday Jun 05, 2024 by Dow Jones
May 28, 2024
DJ Tango Therapeutics Is Maintained at Buy by HC Wainwright & Co., from 6:50AM ET on Tuesday May 28, 2024 by Dow Jones
6:50AM ET on Tuesday May 28, 2024 by Dow Jones
May 24, 2024
DJ Tango Therapeutics Is Maintained at Overweight by Barclays, from 11:06AM ET on Friday May 24, 2024 by Dow Jones
11:06AM ET on Friday May 24, 2024 by Dow Jones
May 23, 2024
DJ Tango Therapeutics Is Maintained at Outperform by Wedbush, from 12:45PM ET on Thursday May 23, 2024 by Dow Jones
12:45PM ET on Thursday May 23, 2024 by Dow JonesMedivir's licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical program, from 9:18AM ET on Thursday May 23, 2024 by Dow Jones
9:18AM ET on Thursday May 23, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Tango Therapeutics Inc | 765.0M | -6.9x | --- |
PureTech Health PLC | 771.7M | -17.9x | --- |
Taysha Gene Therapies Inc | 733.1M | -3.3x | --- |
Stoke Therapeutics Inc | 776.1M | -7.1x | --- |
Mesoblast Ltd | 785.3M | -5.0x | --- |
Exscientia PLC | 441.4M | -3.9x | --- |
Company Information
Tango Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering precision medicine for the treatment of cancer. The Company leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. Its lead program, TNG908, is an methylthioadenosine (MTA)-cooperative inhibitor of protein arginine methyltransferase 5 (PRMT5) designed to work selectively in cancer cells with an methylthioadenosine phosphorylase (MTAP) deletion. Its TNG260 is a first-in-class Co-repressor of Repressor Element-1 Silencing Transcription (CoREST) inhibitor. The Company's programs also include TNG348 and TNG462. TNG348 is an allosteric inhibitor of ubiquitin-specific protease (USP1).
Contact Information
- Headquarters
- 201 Brookline Avenue, Suite 901BOSTON, MA, United States 02215
- Phone
- 857-320-4900
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Alexis Borisy
- President, Chief Executive Officer, Director
- Barbara Weber
- Chief Financial Officer
- Daniella Beckman
- President - Research and Development
- Adam Crystal
- Chief Human Resource Officer
- Julie Carretero
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $765.0M |
|---|---|
Revenue (TTM) | $37.2M |
Shares Outstanding | 106.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.79 |
EPS | $-1.11 |
Book Value | $2.48 |
P/E Ratio | -6.9x |
Price/Sales (TTM) | 20.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -338.80% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
